{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,14]],"date-time":"2026-06-14T17:51:06Z","timestamp":1781459466868,"version":"3.54.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2016,8,17]],"date-time":"2016-08-17T00:00:00Z","timestamp":1471392000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,8,17]],"date-time":"2016-08-17T00:00:00Z","timestamp":1471392000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["HHSN26820041717"],"award-info":[{"award-number":["HHSN26820041717"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Qual Life Res"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1007\/s11136-016-1392-5","type":"journal-article","created":{"date-parts":[[2016,8,17]],"date-time":"2016-08-17T15:18:47Z","timestamp":1471447127000},"page":"349-357","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Recent viral infection in US blood donors and health-related quality of life (HRQOL)"],"prefix":"10.1007","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1130-4643","authenticated-orcid":false,"given":"Farnaz","family":"Vahidnia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan L.","family":"Stramer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debra","family":"Kessler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beth","family":"Shaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"German","family":"Leparc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David E.","family":"Krysztof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone A.","family":"Glynn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Custer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,8,17]]},"reference":[{"key":"1392_CR1","unstructured":"Whitaker, B. I., & Hinkins, S. (2011). The 2011 National blood collection and utilization survey report. Retrieved July 27, 2015, from http:\/\/www.aabb.org\/research\/hemovigilance\/bloodsurvey\/Documents\/11-nbcus-report.pdf ."},{"issue":"RR-4","key":"1392_CR2","first-page":"1","volume":"40","author":"Centers for Disease Control and Prevention (CDC)","year":"1991","unstructured":"Centers for Disease Control and Prevention (CDC). (1991). Public health service inter-agency guidelines for screening donors of blood, plasma, organs, tissues, and semen for evidence of hepatitis B and hepatitis C. MMWR, 40(RR-4), 1\u201317.","journal-title":"MMWR"},{"key":"1392_CR3","unstructured":"U. S. Food and Drug Administration. (2015). Complete list of donor screening assays for infectious agents and HIV diagnostic assays. 2015, from http:\/\/www.fda.gov\/BiologicsBloodVaccines\/BloodBloodProducts\/ApprovedProducts\/LicensedProductsBLAs\/BloodDonorScreening\/InfectiousDisease\/UCM080466 ."},{"issue":"4","key":"1392_CR4","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1089\/apc.2014.0113","volume":"29","author":"LK Brown","year":"2015","unstructured":"Brown, L. K., Whiteley, L., Harper, G. W., Nichols, S., Nieves, A., & Protocol Team for The Adolescent Medicine Trials Network for HIV\/AIDS Interventions. (2015). Psychological symptoms among 2032 youth living with HIV: A multisite study. AIDS Patient Care STDS, 29(4), 212\u2013219.","journal-title":"AIDS Patient Care STDS"},{"issue":"1","key":"1392_CR5","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s11136-005-8485-x","volume":"15","author":"S Honiden","year":"2006","unstructured":"Honiden, S., Sundaram, V., Nease, R. F., Holodniy, M., Lazzeroni, L. C., Zolopa, A., et al. (2006). The effect of diagnosis with HIV infection on health-related quality of life. Quality of Life Research, 15(1), 69\u201382.","journal-title":"Quality of Life Research"},{"issue":"5","key":"1392_CR6","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1002\/hep.510300504","volume":"30","author":"AJ Rodger","year":"1999","unstructured":"Rodger, A. J., Jolley, D., Thompson, S. C., Lanigan, A., & Crofts, N. (1999). The impact of diagnosis of hepatitis C virus on quality of life. Hepatology, 30(5), 1299\u20131301.","journal-title":"Hepatology"},{"issue":"4","key":"1392_CR7","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.jiph.2015.05.004","volume":"9","author":"C Stasi","year":"2015","unstructured":"Stasi, C., Silvestri, C., Voller, F., & Cipriani, F. (2015). The epidemiological changes of HCV and HBV infections in the era of new antiviral therapies and the anti-HBV vaccine. Journal of Infection and Public Health, 9(4), 389\u2013395.","journal-title":"Journal of Infection and Public Health"},{"issue":"8","key":"1392_CR8","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1111\/j.1537-2995.2010.03055.x","volume":"51","author":"F Atsma","year":"2011","unstructured":"Atsma, F., Veldhuizen, I., Verbeek, A., de Kort, W., & de Vegt, F. (2011). Healthy donor effect: Its magnitude in health research among blood donors. Transfusion, 51(8), 1820\u20131828.","journal-title":"Transfusion"},{"issue":"11","key":"1392_CR9","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1111\/j.1537-2995.2007.01425.x","volume":"47","author":"G Edgren","year":"2007","unstructured":"Edgren, G., Tran, T. N., Hjalgrim, H., Rostgaard, K., Shanwell, A., Titlestad, K., et al. (2007). Improving health profile of blood donors as a consequence of transfusion safety efforts. Transfusion, 47(11), 2017\u20132024.","journal-title":"Transfusion"},{"issue":"7","key":"1392_CR10","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1007\/s10198-014-0625-1","volume":"16","author":"E Shehu","year":"2015","unstructured":"Shehu, E., Hofmann, A., Clement, M., & Langmaack, A. C. (2015). Healthy donor effect and satisfaction with health: The role of selection effects related to blood donation behavior. The European Journal of Health Economics, 16(7), 733\u2013745.","journal-title":"The European Journal of Health Economics"},{"issue":"10","key":"1392_CR11","doi-asserted-by":"publisher","first-page":"2479","DOI":"10.1111\/trf.13205","volume":"55","author":"H Ullum","year":"2015","unstructured":"Ullum, H., Rostgaard, K., Kamper-Jorgensen, M., Reilly, M., Melbye, M., Nyren, O., et al. (2015). Blood donation and blood donor mortality after adjustment for a healthy donor effect. Transfusion, 55(10), 2479\u20132485.","journal-title":"Transfusion"},{"issue":"11\u201312","key":"1392_CR12","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1046\/j.1537-2995.1998.38111299056317.x","volume":"38","author":"AM Guiltinan","year":"1998","unstructured":"Guiltinan, A. M., Murphy, E. L., Horton, J. A., Nass, C. C., McEntire, R. L., & Watanabe, K. (1998). Psychological distress in blood donors notified of HTLV-I\/II infection. Retrovirus epidemiology donor study. Transfusion, 38(11\u201312), 1056\u20131062.","journal-title":"Transfusion"},{"issue":"10","key":"1392_CR13","doi-asserted-by":"publisher","first-page":"821","DOI":"10.7326\/0003-4819-142-10-200505170-00007","volume":"142","author":"F Kanwal","year":"2005","unstructured":"Kanwal, F., Gralnek, I. M., Martin, P., Dulai, G. S., Farid, M., & Spiegel, B. M. (2005). Treatment alternatives for chronic hepatitis B virus infection: A cost-effectiveness analysis. Annals of Internal Medicine, 142(10), 821\u2013831.","journal-title":"Annals of Internal Medicine"},{"issue":"4","key":"1392_CR14","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1002\/hep.22138","volume":"47","author":"SC Ong","year":"2008","unstructured":"Ong, S. C., Mak, B., Aung, M. O., Li, S. C., & Lim, S. G. (2008). Health-related quality of life in chronic hepatitis B patients. Hepatology, 47(4), 1108\u20131117.","journal-title":"Hepatology"},{"issue":"7","key":"1392_CR15","first-page":"445","volume":"26","author":"G Woo","year":"2012","unstructured":"Woo, G., Tomlinson, G., Yim, C., Lilly, L., Therapondos, G., Wong, D. K., et al. (2012). Health state utilities and quality of life in patients with hepatitis B. Canadian Journal of Gastroenterology and Hepatology, 26(7), 445\u2013451.","journal-title":"Canadian Journal of Gastroenterology and Hepatology"},{"issue":"11","key":"1392_CR16","doi-asserted-by":"publisher","first-page":"2995","DOI":"10.1007\/s10620-012-2233-1","volume":"57","author":"AC El Khoury","year":"2012","unstructured":"El Khoury, A. C., Vietri, J., & Prajapati, G. (2012). The burden of untreated hepatitis C virus infection: A US patients\u2019 perspective. Digestive Diseases and Sciences, 57(11), 2995\u20133003.","journal-title":"Digestive Diseases and Sciences"},{"issue":"4","key":"1392_CR17","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1002\/hep.20659","volume":"41","author":"BM Spiegel","year":"2005","unstructured":"Spiegel, B. M., Younossi, Z. M., Hays, R. D., Revicki, D., Robbins, S., & Kanwal, F. (2005). Impact of hepatitis C on health related quality of life: A systematic review and quantitative assessment. Hepatology, 41(4), 790\u2013800.","journal-title":"Hepatology"},{"issue":"10","key":"1392_CR18","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1016\/j.drugpo.2015.04.019","volume":"26","author":"D Whiteley","year":"2015","unstructured":"Whiteley, D., Elliott, L., Cunningham-Burley, S., & Whittaker, A. (2015). Health-related quality of life for individuals with hepatitis C: A narrative review. International Journal of Drug Policy, 26(10), 936\u2013949.","journal-title":"International Journal of Drug Policy"},{"issue":"1","key":"1392_CR19","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1590\/S1413-86702009000100003","volume":"13","author":"AG Carvalho","year":"2009","unstructured":"Carvalho, A. G., Galvao-Phileto, A. V., Lima, N. S., Jesus, R. S., Galvao-Castro, B., & Lima, M. G. (2009). Frequency of mental disturbances in HTLV-1 patients in the state of Bahia, Brazil. Brazilian Journal of Infectious Diseases, 13(1), 5\u20138.","journal-title":"Brazilian Journal of Infectious Diseases"},{"issue":"1","key":"1392_CR20","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1111\/j.1537-2995.2012.03677.x","volume":"53","author":"AM Guiltinan","year":"2013","unstructured":"Guiltinan, A. M., Kaidarova, Z., Behan, D., Marosi, C., Hutching, S., Kaiser, M., et al. (2013). Major depression and generalized anxiety disorder among human T-lymphotropic virus types I- and II-infected former blood donors. Transfusion, 53(1), 60\u201368.","journal-title":"Transfusion"},{"issue":"7","key":"1392_CR21","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1007\/s11136-012-0283-7","volume":"22","author":"J Gillis","year":"2013","unstructured":"Gillis, J., Cooper, C., Rourke, S., Rueda, S., O\u2019Brien, K., Collins, E., et al. (2013). Impact of hepatitis B and C co-infection on health-related quality of life in HIV positive individuals. Quality of Life Research, 22(7), 1525\u20131535.","journal-title":"Quality of Life Research"},{"issue":"9","key":"1392_CR22","doi-asserted-by":"publisher","first-page":"1984","DOI":"10.1111\/j.1572-0241.2005.41962.x","volume":"100","author":"F Kanwal","year":"2005","unstructured":"Kanwal, F., Gralnek, I. M., Hays, R. D., Dulai, G. S., Spiegel, B. M., Bozzette, S., et al. (2005). Impact of chronic viral hepatitis on health-related quality of life in HIV: Results from a nationally representative sample. American Journal of Gastroenterology, 100(9), 1984\u20131994.","journal-title":"American Journal of Gastroenterology"},{"issue":"5","key":"1392_CR23","doi-asserted-by":"publisher","first-page":"337","DOI":"10.3109\/07853890109002087","volume":"33","author":"R Rabin","year":"2001","unstructured":"Rabin, R., & de Charro, F. (2001). EQ-5D: A measure of health status from the EuroQol Group. Annals of Medicine, 33(5), 337\u2013343.","journal-title":"Annals of Medicine"},{"issue":"7","key":"1392_CR24","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1007\/s11136-012-0322-4","volume":"22","author":"MF Janssen","year":"2013","unstructured":"Janssen, M. F., Pickard, A. S., Golicki, D., Gudex, C., Niewada, M., Scalone, L., et al. (2013). Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L across eight patient groups: A multi-country study. Quality of Life Research, 22(7), 1717\u20131727.","journal-title":"Quality of Life Research"},{"issue":"1","key":"1392_CR25","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1097\/00005650-200001000-00013","volume":"38","author":"JA Johnson","year":"2000","unstructured":"Johnson, J. A., & Pickard, A. S. (2000). Comparison of the EQ-5D and SF-12 health surveys in a general population survey in Alberta, Canada. Medical Care, 38(1), 115\u2013121.","journal-title":"Medical Care"},{"issue":"1","key":"1392_CR26","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/0168-8510(96)00822-6","volume":"37","author":"R Brooks","year":"1996","unstructured":"Brooks, R. (1996). EuroQol: The current state of play. Health Policy, 37(1), 53\u201372.","journal-title":"Health Policy"},{"issue":"5","key":"1392_CR27","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1111\/trf.12951","volume":"55","author":"B Custer","year":"2015","unstructured":"Custer, B., Kessler, D., Vahidnia, F., Leparc, G., Krysztof, D. E., Shaz, B., et al. (2015). Risk factors for retrovirus and hepatitis virus infections in accepted blood donors. Transfusion, 55(5), 1098\u20131107.","journal-title":"Transfusion"},{"issue":"2","key":"1392_CR28","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1046\/j.1537-2995.2003.00291.x","volume":"43","author":"UK Sharma","year":"2003","unstructured":"Sharma, U. K., Stramer, S. L., Wright, D. J., Glynn, S. A., Hermansen, S., Schreiber, G. B., et al. (2003). Impact of changes in viral marker screening assays. Transfusion, 43(2), 202\u2013214.","journal-title":"Transfusion"},{"issue":"2","key":"1392_CR29","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1111\/j.1537-2995.2008.01952.x","volume":"49","author":"B Custer","year":"2009","unstructured":"Custer, B., Kamel, H., Kiely, N. E., Murphy, E. L., & Busch, M. P. (2009). Associations between West Nile virus infection and symptoms reported by blood donors identified through nucleic acid test screening. Transfusion, 49(2), 278\u2013288.","journal-title":"Transfusion"},{"issue":"3","key":"1392_CR30","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/0168-8510(90)90421-9","volume":"16","author":"The EuroQol Group","year":"1990","unstructured":"The EuroQol Group. (1990). EuroQol\u2014a new facility for the measurement of health-related quality of life. Health Policy, 16(3), 199\u2013208.","journal-title":"Health Policy"},{"key":"1392_CR31","volume-title":"EQ-5D-3L user guide, basic information on how to use the EQ-5D-3L instrument","author":"M Oemar","year":"2013","unstructured":"Oemar, M., & Oppe, M. (2013). EQ-5D-3L user guide, basic information on how to use the EQ-5D-3L instrument (5.0th ed.). The Netherlands: EuroQoL Group.","edition":"5.0"},{"issue":"3","key":"1392_CR32","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1097\/00005650-200503000-00003","volume":"43","author":"JW Shaw","year":"2005","unstructured":"Shaw, J. W., Johnson, J. A., & Coons, S. J. (2005). US valuation of the EQ-5D health states: Development and testing of the D1 valuation model. Medical Care, 43(3), 203\u2013220.","journal-title":"Medical Care"},{"issue":"5 Suppl","key":"1392_CR33","first-page":"MS274","volume":"30","author":"DA Revicki","year":"1992","unstructured":"Revicki, D. A. (1992). Relationship between health utility and psychometric health status measures. Medical Care, 30(5 Suppl), MS274\u2013MS282.","journal-title":"Medical Care"},{"issue":"6","key":"1392_CR34","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.bjhh.2015.08.004","volume":"37","author":"FA Ferreira","year":"2015","unstructured":"Ferreira, F. A., de Almeida-Neto, C., Teixeira, M. C., & Strauss, E. (2015). Health-related quality of life among blood donors with hepatitis B and hepatitis C: Longitudinal study before and after diagnosis. Revista Brasileira de Hematologia e Hemoterapia, 37(6), 381\u2013387.","journal-title":"Revista Brasileira de Hematologia e Hemoterapia"},{"issue":"1","key":"1392_CR35","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1111\/j.0041-1132.2004.00620.x","volume":"44","author":"JD McAuley","year":"2004","unstructured":"McAuley, J. D., Caglioti, S., Williams, R. C., Robertson, G. F., Morgan, L., Tobler, L. H., et al. (2004). Clinical significance of nondiscriminated reactive results with the Chiron Procleix HIV-1 and HCV assay. Transfusion, 44(1), 91\u201396.","journal-title":"Transfusion"},{"issue":"8","key":"1392_CR36","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1111\/trf.13678","volume":"56","author":"F Vahidnia","year":"2016","unstructured":"Vahidnia, F., Stramer, S. L., Kessler, D., Goncalez, T. T., Shaz, B. H., Leparc, G., et al. (2016). Motivations for donating and attitudes toward screening policies in US blood donors with viral infection. Transfusion, 56(8), 2013\u20132020.","journal-title":"Transfusion"},{"issue":"4","key":"1392_CR37","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1111\/j.1365-2893.2010.01292.x","volume":"18","author":"HL Tillmann","year":"2011","unstructured":"Tillmann, H. L., Wiese, M., Braun, Y., Wiegand, J., Tenckhoff, S., Mossner, J., et al. (2011). Quality of life in patients with various liver diseases: Patients with HCV show greater mental impairment, while patients with PBC have greater physical impairment. Journal of Viral Hepatitis, 18(4), 252\u2013261.","journal-title":"Journal of Viral Hepatitis"},{"issue":"11","key":"1392_CR38","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1136\/gut.2007.142844","volume":"57","author":"B Helbling","year":"2008","unstructured":"Helbling, B., Overbeck, K., Gonvers, J. J., Malinverni, R., Dufour, J. F., Borovicka, J., et al. (2008). Host-rather than virus-related factors reduce health-related quality of life in hepatitis C virus infection. Gut, 57(11), 1597\u20131603.","journal-title":"Gut"},{"issue":"8","key":"1392_CR39","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1097\/01.mcg.0000173860.08478.a6","volume":"39","author":"PJ Rowan","year":"2005","unstructured":"Rowan, P. J., Al-Jurdi, R., Tavakoli-Tabasi, S., Kunik, M. E., Satrom, S. L., & El-Serag, H. B. (2005). Physical and psychosocial contributors to quality of life in veterans with hepatitis C not on antiviral therapy. Journal of Clinical Gastroenterology, 39(8), 731\u2013736.","journal-title":"Journal of Clinical Gastroenterology"},{"issue":"9859","key":"1392_CR40","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1016\/S0140-6736(12)61728-0","volume":"380","author":"R Lozano","year":"2012","unstructured":"Lozano, R., Naghavi, M., Foreman, K., Lim, S., Shibuya, K., Aboyans, V., et al. (2012). Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the global burden of disease study 2010. Lancet, 380(9859), 2095\u20132128.","journal-title":"Lancet"},{"key":"1392_CR41","unstructured":"World Health Organization. (2015). Fact sheet N\u25e6164., Hepatitis C. Retrieved Febraury 11, 2016, from http:\/\/www.who.int\/mediacentre\/factsheets\/fs164\/en\/ ."},{"key":"1392_CR42","unstructured":"World Health Organization. (2015). Fact sheet N\u25e6204., Hepatitis B. Retrieved July 29, 2015, from http:\/\/www.who.int\/mediacentre\/factsheets\/fs204\/en\/ ."},{"issue":"3","key":"1392_CR43","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/BF00435221","volume":"2","author":"J Brazier","year":"1993","unstructured":"Brazier, J., Jones, N., & Kind, P. (1993). Testing the validity of the Euroqol and comparing it with the SF-36 health survey questionnaire. Quality of Life Research, 2(3), 169\u2013180.","journal-title":"Quality of Life Research"}],"container-title":["Quality of Life Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11136-016-1392-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11136-016-1392-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11136-016-1392-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11136-016-1392-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,18]],"date-time":"2024-06-18T22:19:51Z","timestamp":1718749191000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11136-016-1392-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,17]]},"references-count":43,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["1392"],"URL":"https:\/\/doi.org\/10.1007\/s11136-016-1392-5","relation":{},"ISSN":["0962-9343","1573-2649"],"issn-type":[{"value":"0962-9343","type":"print"},{"value":"1573-2649","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,17]]},"assertion":[{"value":"11 August 2016","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2016","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Authors disclose no potential conflict of interest for the submitted work in the past 3\u00a0years.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in this study involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. This article does not contain any studies with animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and animal rights statement"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}